drugset / Trial / NCT01278498

The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients

NCT01278498

Phase 4 Unknown 444 enrolled Asan Medical Center Dong-A ST Co., Ltd. · collab
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Through this study, the investigators are to demonstrate the superiority of Escitalopram over placebo for the prevention of poststroke depression in patients with acute stroke The primary hypothesis of this study is; This study will prove the superiority of Escitalopram on the prevention of poststroke depression in patients with acute stroke against placebo

Timeline

Start
2011-01
Primary completion
2014-12
Completion
2015-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Escitalopram Small molecule 10 mg Oral

Indications